Skip to main content
Clinical Trials/CTRI/2020/12/029656
CTRI/2020/12/029656
Not yet recruiting
Phase 2

A Randomized Controlled Trial evaluating efficacy of Intravenous Albumin Infusion with Corticosteroids and Exclusive Enteral Nutrition (EEN) versus Corticosteroids and EEN alone in patients with Acute Severe Ulcerative Colitis

AIIMS0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K50-K52- Noninfective enteritis and colitis
Sponsor
AIIMS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AIIMS

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with Acute Severe Ulcerative Colitis as defined by Truelove and Wittâ??s criteria
  • 2\) Patients giving written informed consent

Exclusion Criteria

  • 1\) Age \< 18 years, \>75 years
  • 2\) Patients with indeterminate form of colitis or Crohnâ??s colitis
  • 3\) Patients with infection related flares
  • 4\) Patients with infective colitis or colitis of other etiologies
  • 5\) ASUC patients having toxic megacolon, paralytic ileus or perforation
  • 6\) Pregnancy
  • 7\) Patient who have received any dose of steroids or biologics for treatment of index episode before coming to this center
  • 8\) Other major co\-morbid conditions like acute myocardial infarction, chronic kidney disease or chronic liver disease, congestive heart failure or acute kidney disease

Outcomes

Primary Outcomes

Not specified

Similar Trials